Refractory Aggressive T-Cell Non-Hodgkin Lymphoma

general

50

Centers

59

Active Trials

$13.2B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Refractory B Lymphoblastic Lymphoma50

Top Centers for Refractory Aggressive T-Cell Non-Hodgkin Lymphoma(50)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
2
NCI Comprehensive
3
NCI Comprehensive
4
5
NCI Comprehensive
6
NCI Comprehensive
7
NCI Comprehensive
8
NCI Comprehensive
9
NCI Comprehensive
10
11
NCI Comprehensive
12
13
14
15
16
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
17
NCI Comprehensive
18
NCI Comprehensive
19
NCI Clinical
20
NCI Comprehensive
21
NCI Comprehensive
22
23
NCI Comprehensive
24
25
Cedars-Sinai CancerLos Angeles, CA
26
27
28
NCI Comprehensive
29
30
31
NCI Comprehensive
32
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →